Ticker
TVRDCompany Name
TVARDI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -13.84M | -210.4% | $ 6.58M |
3/31/2025 | $ -36.12M | -477.04% | $ 7.57M |
12/31/2024 | $ -62.79M | -879.81% | $ 7.14M |
9/30/2024 | $ -89.07M | -1025.43% | $ 8.69M |
6/30/2024 | $ -106.58M | -969.31% | $ 11M |
3/31/2024 | $ -119.96M | -708.22% | $ 16.94M |
12/31/2023 | $ -117.91M | -562.33% | $ 20.97M |
9/30/2023 | $ -116.52M | -548.95% | $ 21.23M |
6/30/2023 | $ -111.66M | -410.95% | $ 27.17M |
3/31/2023 | $ -84.39M | -195.16% | $ 43.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for TVARDI THERAPEUTICS INC is calculated as follows: EBIT [ $ -99.71M ] / Revenues [ $ 27.5M ]
(=) EBIT % [ -362.54% ]
Minimum
Sep 30, 2024
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |